Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The naloxone spray market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 22%, as per The Business Research Company’s market report!

Read More On The Naloxone Spray Market Report 2022 – https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report

The Naloxone Spray Market Size In 2022 And Forecast
The global naloxone spray market is expected to grow from $285.09 million in 2020 to $351.39 million in 2021 at a compound annual growth rate (CAGR) of 23.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The naloxone spray market is expected to reach $785.35 million in 2025 at a CAGR of 22.3%.

The naloxone spray market consists of sales of naloxone spray by entities (organizations, sole traders, and partnerships) which is prefilled with naloxone a needle-free device that is sprayed into one nostril, and requires no assembly.

Request for A Free Sample Of The Global Naloxone Spray Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp

Increase In The Prevalence Of Opioid Overdoses Is Driving The Growth Of The Naloxone Spray Market
For instance, in 2019, opioids were involved in 49,860 overdose deaths (70.6% of all drug overdose deaths). According to WHO, as of 2020, more than 70% of deaths are related to opioids, and out of these 30% of deaths are caused by overdose. As a part of emergency medical treatment, naloxone nasal spray is used to reverse the life-threatening effects of opiate or opioids overdose. Thus, the increasing prevalence of opioid overdoses will drive the growth of the naloxone spray market.

Competitive Landscape And The Regional Analysis Of The Naloxone Spray Market
Major players in the naloxone spray market are Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries Ltd., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior PLC, Samarth Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., and Neon Laboratories Limited.

The Naloxone Spray Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the naloxone spray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the naloxone spray market.

Increasing Product Approvals – A Key Trend In The Naloxone Spray Market
Major companies manufacturing naloxone sprays are focused on new product approvals to broaden their product portfolios and expand their naloxone spray business.

Naloxone Spray Market Segmentation By The Business Research Company

1) By Dosage: 2 mg/Actuation, 4 mg/Actuation

2) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others

Here Are Some Reports Related To The Naloxone Spray Market –

Analgesics Global Market Report 2022

Neurostimulation Devices Global Market Report 2022

Antiemetics And Antinauseants Global Market Report 2022

Get In Touch With Us – Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found This Article Helpful? Share It On: